Oroxylin A attenuates osteoarthritis progression by dual inhibition of cell inflammation and hypertrophy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Oroxylin A attenuates osteoarthritis progression by dual inhibition of cell inflammation and hypertrophy

Published:2021 Issue:1 Volume:12 Page:328-339
ISSN:2042-6496
Container-title:Food & Function
language:en
Short-container-title:Food Funct.

Author:

Chen De-Heng¹²³⁴,Zheng Gang¹²³⁴,Zhong Xin-Yang⁵⁶⁴,Lin Zi-Hao⁵⁶⁴,Yang Shi-Wei⁵⁶⁴,Liu Hai-Xiao¹²³⁴^ORCID,Shang Ping⁷²³⁴^ORCID

Affiliation:

1. Department of Orthopaedic Surgery

2. The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University

3. 325027 Wenzhou

4. China

5. The Second School of Medicine

6. Wenzhou Medical University

7. Department of Rehabilitation

Abstract

Oroxylin A is a promising agent to prevent osteoarthritis development by targeting cell inflammation and hypertrophy.

Funder

Department of Education of Zhejiang Province

Science and Technology Plan Project of Wenzhou, China

Publisher

Royal Society of Chemistry (RSC)

Subject

General Medicine,Food Science

Link

http://pubs.rsc.org/en/content/articlepdf/2021/FO/D0FO02159H

Reference55 articles.

1. Osteoarthritis

2. Epidemiology of Osteoarthritis

3. A meta-analysis of sex differences prevalence, incidence and severity of osteoarthritis

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Oroxylin A inhibits inflammatory cytokines in periodontitis via HO‑1;Molecular Medicine Reports;2024-05-20

2. Oroxylin A: Nature's arsenal against liver fibrosis, cancer, and inflammatory diseases;Health Sciences Review;2024-03

3. Osteoarthritis in the Elderly Population: Preclinical Evidence of Nutrigenomic Activities of Flavonoids;Nutrients;2023-12-28

4. Targeting WNT signalling pathways as new therapeutic strategies for osteoarthritis;Journal of Drug Targeting;2023-11-20

5. Oroxylin A relieves intrauterine adhesion in mice through inhibiting macrophage pyroptosis via SIRT3-SOD2-ROS pathway;International Immunopharmacology;2023-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3